BIXT Message Board Post 28352648 | Bioxytran Inc
home / stock / bixt / bixt message board
steffanhen570
()
Posted on: Sep/20/2023 08:06:58
Finally, Bioxytran, Inc. is clearly building a name for itself in the worlds of biotechnology and healthcare innovation. Their dedication to discovering ground-breaking solutions for important medical concerns, such as COVID-19, has the potential to produce extraordinary returns for investors. As the company continues to hit milestones and improve its research, it remains an appealing option for investors wanting both financial and societal benefit.
News, Short Squeeze, Breakout and More Instantly...
-
BXT-25 is expected to oxygenate the brain BOSTON, MASSACHUSETTS, June 27, 2024 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing drugs to treat stroke and Alzheimer's disease, announced that Bioxtran’s...
-
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
-
AIA Group Limited ADR (AAGIY) is expected to report for Q4 2023 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 SecureWorks Corp. (SCWX) is expected to report $-0.15 for Q4 2024 Acacia Research Corporation (ACTG) is expected to report for quarter end...